Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 1 | 12189511 | intron variant | A/C | snv | 8.0E-02 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1 | 12191284 | intron variant | A/C | snv | 5.2E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.776 | 0.320 | 1 | 12207208 | 3 prime UTR variant | A/G | snv | 0.48 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.320 | 1 | 12207208 | 3 prime UTR variant | A/G | snv | 0.48 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.776 | 0.320 | 1 | 12207208 | 3 prime UTR variant | A/G | snv | 0.48 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.320 | 1 | 12207208 | 3 prime UTR variant | A/G | snv | 0.48 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.320 | 1 | 12207208 | 3 prime UTR variant | A/G | snv | 0.48 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.320 | 1 | 12207208 | 3 prime UTR variant | A/G | snv | 0.48 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.776 | 0.320 | 1 | 12207208 | 3 prime UTR variant | A/G | snv | 0.48 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.776 | 0.320 | 1 | 12207208 | 3 prime UTR variant | A/G | snv | 0.48 |
|
Infections | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 1 | 12202039 | missense variant | A/G | snv | 4.2E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.080 | 1 | 12188885 | synonymous variant | A/G | snv | 0.22 | 0.22 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
1 | 12209567 | downstream gene variant | C/A;G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
1 | 12209567 | downstream gene variant | C/A;G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
1 | 12209567 | downstream gene variant | C/A;G;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
1.000 | 0.080 | 1 | 12192924 | missense variant | C/G | snv | 2.1E-03 | 1.8E-03 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||||
|
1.000 | 0.040 | 1 | 12188800 | missense variant | C/T | snv | 4.0E-06 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 1 | 12203488 | intron variant | C/T | snv | 0.20 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 1 | 12207235 | 3 prime UTR variant | C/T | snv | 0.51 |
|
Infections | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1 | 12186118 | intron variant | C/T | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1 | 12187071 | intron variant | C/T | snv | 2.2E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.080 | 1 | 12193005 | missense variant | G/A | snv | 2.7E-02 | 2.5E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | < 0.001 | 1 | 2000 | 2000 | ||||||
|
1 | 12166729 | upstream gene variant | GCCGGGCAGGTGGAG/-;GCCGGGCAGGTGGAGGCCGGGCAGGTGGAG | delins | 0.30 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 0.080 | 1 | 12165294 | upstream gene variant | T/A | snv | 0.14 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 1 | 12198174 | intron variant | T/C | snv | 0.23 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |